Famotidine and calcium carbonate drug interaction
Pro Research Analysisby 
Searched over 200M research papers
Famotidine and Calcium Carbonate Drug Interaction: Pharmacokinetics and Clinical Implications
Pharmacokinetic Interaction Between Famotidine and Calcium Carbonate
Research shows that when famotidine is administered together with calcium carbonate (often in fixed-dose combination formulations), there is no significant effect on the pharmacokinetics of famotidine. Plasma concentration profiles, maximal concentration (Cmax), and area under the curve (AUC) for famotidine remain similar whether or not calcium carbonate is present, indicating that calcium carbonate does not significantly alter the absorption or bioavailability of famotidine itself .
Detection and Clinical Significance of Drug-Drug Interactions
Studies using drug interaction checking programs have identified a minor interaction between calcium carbonate and famotidine. However, this interaction is generally considered clinically insignificant and is detected by only some databases. Most antacid-induced drug interactions, including those involving calcium carbonate and famotidine, are found to be moderate or minor in severity .
Effects on Phosphate Binding in Hemodialysis Patients
In patients undergoing hemodialysis, the co-administration of famotidine with calcium carbonate can reduce the effectiveness of calcium carbonate as a phosphate binder. Multiple studies have shown that famotidine increases serum phosphate levels in these patients, suggesting that it interferes with the phosphate-binding ability of calcium carbonate 345. This effect is observed even at the recommended dose of famotidine for hemodialysis patients. The interaction does not appear to affect the phosphate-binding ability of other calcium salts, such as calcium lactate .
Impact on Calcium Absorption
There is evidence that famotidine can increase intragastric pH, which may reduce the solubility and absorption of calcium from calcium carbonate. In one reported case, a patient experienced decreased serum calcium levels and symptoms of tetany after starting famotidine alongside calcium carbonate, which resolved upon discontinuation of famotidine. This suggests that the increased gastric pH caused by famotidine can make calcium carbonate less soluble and less absorbable in the intestine .
Comparative Effects on Gastric Acid and Duration of Action
Famotidine and calcium carbonate have different effects on gastric acid. Calcium carbonate acts quickly to neutralize stomach acid but has a short duration of action, while famotidine has a slower onset but a much longer duration of acid suppression. Their peak acid-reducing effects are similar, but the timing and duration differ significantly .
Conclusion
In summary, while calcium carbonate does not significantly affect the pharmacokinetics of famotidine, famotidine can reduce the effectiveness of calcium carbonate as a phosphate binder in hemodialysis patients and may decrease calcium absorption by increasing gastric pH. The clinical significance of this interaction is most relevant in populations with altered calcium or phosphate metabolism, such as those with chronic kidney disease or hypoparathyroidism. For most other patients, the interaction is minor and unlikely to cause significant problems. Careful monitoring is recommended when these drugs are used together in at-risk populations.
Sources and full results
Most relevant research papers on this topic